Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence (Q40417738)

20 September 2017

Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence (English)

1 reference

20 September 2017

phase III clinical trial

0 references

1 reference

4

Janine G Einspahr

1 reference

20 September 2017

1

David S Alberts

1 reference

20 September 2017

María Elena Martínez

2

1 reference

20 September 2017

Lisa M Hess

3

1 reference

20 September 2017

Sylvan B Green

5

1 reference

20 September 2017

A K Bhattacharyya

6

1 reference

20 September 2017

Jose Guillen

7

1 reference

20 September 2017

Mary Krutzsch

8

1 reference

20 September 2017

Ashok K Batta

9

1 reference

20 September 2017

Gerald Salen

10

1 reference

20 September 2017

Liane Fales

11

1 reference

20 September 2017

Kris Koonce

12

1 reference

20 September 2017

Dianne Parish

13

1 reference

20 September 2017

Mary Clouser

14

1 reference

20 September 2017

Denise Roe

15

1 reference

20 September 2017

Peter Lance

16

1 reference

20 September 2017

Phoenix and Tucson Gastroenterologist Networks

17

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Journal of the National Cancer Institute

20 September 2017

1 reference

20 September 2017

97

1 reference

20 September 2017

846-853

1 reference

20 September 2017

11

1 reference

20 September 2017

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Relationship between duodenal bile acids and colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Unconjugated secondary bile acids in the serum of patients with colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

The mutagenicity of bile acids using a fluctuation test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

A BALANCING VIEW: Dysplasia surveillance in ulcerative colitis--sorting the pro from the con.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Selective preservation of protein kinase C-zeta in the chemoprevention of azoxymethane-induced colonic tumors by piroxicam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJI144

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJI144

1 reference

release_7iaepqmmvjgdrdps243a5755zy

20 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7iaepqmmvjgdrdps243a5755zy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference